These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9570331)

  • 1. Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat models.
    Mollison KW; Fey TA; Krause RA; Andrews JM; Bretheim PT; Cusick PK; Hsieh GC; Luly JR
    Toxicology; 1998 Feb; 125(2-3):169-81. PubMed ID: 9570331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assay.
    Mollison KW; Fey TA; Krause RA; Andrews JM; Bretheim PT; Brandt JA; Kawai M; Wagner R; Hsieh GC; Luly JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1509-19. PubMed ID: 9400028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tacrolimus-related immunosuppressant with reduced toxicity.
    Dumont FJ; Koprak S; Staruch MJ; Talento A; Koo G; DaSilva C; Sinclair PJ; Wong F; Woods J; Barker J; Pivnichny J; Singer I; Sigal NH; Williamson AR; Parsons WH; Wyvratt M
    Transplantation; 1998 Jan; 65(1):18-26. PubMed ID: 9448138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity.
    Armstrong HM; Wong F; Holmes MA; Sinclair PJ; Goulet MT; Dumont FJ; Staruch MJ; Koprak S; Peterson LB; Rosa R; Wilusz MB; Wiederrecht GJ; Cryan JG; Wyvratt MJ; Parsons WH
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2089-94. PubMed ID: 10450987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
    Mollison KW; Fey TA; Gauvin DM; Sheets MP; Smith ML; Pong M; Krause R; Miller L; Or YS; Kawai M; Wagner R; Wiedeman PE; Clark RF; Gunawardana IW; Rhoades TA; Henry CL; Tu NP; BaMaung NY; Kopecka H; Liu L; Xie Q; Lane BC; Trevillyan JM; Marsh K; Luly JR
    Curr Pharm Des; 1998 Oct; 4(5):367-79. PubMed ID: 10197049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal endothelin in FK506-induced nephrotoxicity in spontaneously hypertensive rats.
    Uchida J; Miura K; Yamanaka S; Kim S; Iwao H; Nakatani T; Kishimoto T
    Jpn J Pharmacol; 1998 Jan; 76(1):39-49. PubMed ID: 9517403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on an immunosuppressive macrolactam, ascomycin: synthesis of a C-33 hydroxyl derivative.
    Kawai M; Gunawardana IW; Mollison KW; Hsieh GC; Lane BC; Luly JR
    Bioorg Med Chem Lett; 1998 Apr; 8(8):935-8. PubMed ID: 9871515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants.
    Sierra-Paredes G; Sierra-Marcuño G
    CNS Neurosci Ther; 2008; 14(1):36-46. PubMed ID: 18482098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potential.
    Goulet MT; McAlpine SR; Staruch MJ; Koprak S; Dumont FJ; Cryan JG; Wiederrecht GJ; Rosa R; Wilusz MB; Peterson LB; Wyvratt MJ; Parsons WH
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2253-8. PubMed ID: 9873523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
    Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
    Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.
    McLaughlin GE; Schober M; Perez M; Ruiz P; Steele BW; Abitbol C
    Pediatr Nephrol; 2003 Sep; 18(9):860-4. PubMed ID: 12836095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy.
    Tamada S; Nakatani T; Asai T; Tashiro K; Komiya T; Sumi T; Okamura M; Kim S; Iwao H; Kishimoto T; Yamanaka S; Miura K
    Kidney Int; 2003 Jan; 63(1):306-14. PubMed ID: 12472797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
    Andoh TF; Burdmann EA; Fransechini N; Houghton DC; Bennett WM
    Kidney Int; 1996 Oct; 50(4):1110-7. PubMed ID: 8887267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.
    Tada H; Yanagiwara S; Ito K; Suzuki T
    Pharmacol Toxicol; 1999 Jun; 84(6):241-6. PubMed ID: 10401724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats.
    Wang L; Kubodera S; Ueno A; Takeda M
    Ren Fail; 2001 Jan; 23(1):11-9. PubMed ID: 11256520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.
    Shihab FS; Bennett WM; Tanner AM; Andoh TF
    Transplantation; 1997 Dec; 64(12):1829-37. PubMed ID: 9422427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein.
    Becker JW; Rotonda J; Cryan JG; Martin M; Parsons WH; Sinclair PJ; Wiederrecht G; Wong F
    J Med Chem; 1999 Jul; 42(15):2798-804. PubMed ID: 10425089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.